A Novel Anti-CD47 Nanobody Tetramer for Cancer Therapy
CD47 acts as a defense mechanism for tumor cells by sending a “don’t eat me” signal via its bond with SIRPα. With CD47’s overexpression linked to poor cancer outcomes, its pathway has become a target in cancer immunotherapy. Though monoclonal antibodies offer specificity, they have limitations like...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2024-01-01
|
| coleção: | Antibodies |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2073-4468/13/1/2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|